Patent · US Active

Vector production

US11957747B2 · kind B2 · utility

0Cited by
2References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 7, 2021
Grant dateApr 16, 2024
Priority date
Expiry dateSep 5, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An enveloped viral particle producer or packaging cell, wherein the cell is genetically engineered to decrease expression of MHC-I on the surface of the cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.